StockData
Kura Oncology, Inc. logo

Kura Oncology, Inc. (KURA) stock

KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$7.34−0.15 (-2.00%)

Close on Nov 18, 2026Market cap $652.97MP/E –Yield –

Kura Oncology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Kura Oncology's total debt was $9.83M at Sep 30, 2026. For fiscal 2025 it was $9.71M, up 2.0% from the year before. The highest annual figure on record is $9.71M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.71M+2.0%
FY2024Dec 31, 2024$9.52M+2.0%
FY2023Dec 31, 2023$9.33M+1.9%
FY2022Dec 31, 2022$9.16M+26.3%
FY2020Dec 31, 2020$7.25M-3.3%
FY2019Dec 31, 2019$7.50M0.0%
FY2018Dec 31, 2018$7.50M+5.7%
FY2017Dec 31, 2017$7.10M-3.1%
FY2016Dec 31, 2016$7.32M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$9.83M+1.7%
Q2 FY2026Jun 30, 2026$9.79M+1.8%
Q1 FY2026Mar 31, 2026$9.75M+1.9%
Q4 FY2025Dec 31, 2025$9.71M+2.0%
Q3 FY2025Sep 30, 2025$9.67M+2.1%
Q2 FY2025Jun 30, 2025$9.62M+2.1%
Q1 FY2025Mar 31, 2025$9.57M+2.1%
Q4 FY2024Dec 31, 2024$9.52M+2.0%
Q3 FY2024Sep 30, 2024$9.47M+2.0%
Q2 FY2024Jun 30, 2024$9.42M+1.9%
Q1 FY2024Mar 31, 2024$9.38M+1.9%
Q4 FY2023Dec 31, 2023$9.33M+1.9%
Q3 FY2023Sep 30, 2023$9.29M+42.9%
Q2 FY2023Jun 30, 2023$9.24M+27.5%
Q1 FY2023Mar 31, 2023$9.20M+22.7%
Q4 FY2022Dec 31, 2022$9.16M+22.1%
Q1 FY2021Mar 31, 2021$6.50M-13.3%
Q4 FY2020Dec 31, 2020$7.25M-3.3%
Q3 FY2020Sep 30, 2020$7.50M0.0%
Q2 FY2020Jun 30, 2020$7.50M0.0%
Q1 FY2020Mar 31, 2020$7.50M0.0%
Q4 FY2019Dec 31, 2019$7.50M0.0%
Q3 FY2019Sep 30, 2019$7.50M+19.7%
Q2 FY2019Jun 30, 2019$7.50M+7.7%
Q1 FY2019Mar 31, 2019$7.50M+4.8%
Q4 FY2018Dec 31, 2018$7.50M+5.7%
Q3 FY2018Sep 30, 2018$6.27M-11.0%
Q2 FY2018Jun 30, 2018$6.96M-5.3%
Q1 FY2018Mar 31, 2018$7.16M-2.5%
Q4 FY2017Dec 31, 2017$7.10M-3.1%
Q3 FY2017Sep 30, 2017$7.04M–
Q2 FY2017Jun 30, 2017$7.36M–
Q1 FY2017Mar 31, 2017$7.34M–
Q4 FY2016Dec 31, 2016$7.32M–

More Kura Oncology figures

See a number that looks wrong?